CPHI - China Pharma Holdings, Inc. Company Cash Volume

The cash liquidity metric demonstrates a steady cash flow, where the 0.00 mark serves as a key figure for China Pharma Holdings (CPHI). Stable cash supports the mature prescription drug segment. Revenues are based on a wide range of antibiotics and government contracts in the PRC. Additionally, amortized generics for CNS therapy, which require no new R&D expenditures, generate capital.
Financial and market metric breakdowns for China Pharma Holdings (CPHI)

This indicator tracks the volume of highly liquid assets available for immediate use. Analyzing this metric allows for an assessment of the issuer's solvency and its resilience to market volatility. The trend in the company's cash position reflects the balance between financial security and capital efficiency. For China Pharma Holdings (CPHI), such reserves are critical when implementing robotic screening systems. Sufficient liquidity ensures the seamless deployment of software robots for processing clinical trial data.